MyMD Pharmaceuticals (MYMD) Institutional Ownership $1.33 -0.09 (-6.34%) (As of 11/1/2024 ET) Add Compare Share Share Ownership Stock AnalysisChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends Institutional Ownership Changes (13F Filings) for MyMD Pharmaceuticals (NASDAQ:MYMD)CurrentInstitutional OwnershipPercentage9.64%Number ofInstitutional Buyers(last 12 months)2TotalInstitutional Inflows(last 12 months)$18.80MNumber ofInstitutional Sellers(last 12 months)1TotalInstitutional Outflows(last 12 months)$5.34M Get MYMD Insider Trade Alerts Want to know when executives and insiders are buying or selling MyMD Pharmaceuticals stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address Skip Chart & View Institutional Buying and Selling Data MYMD Institutional Buying and Selling by Quarter Ad Porter & CompanyTrue paradigm shiftI thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we are, a quarter of a century later, almost to the exact day, and it’s happening again. Here’s the full story for you. MyMD Pharmaceuticals Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails5/1/2024 Mirae Asset Global Investments Co. Ltd.875,933$2.09M0.0%-71.8%40.552% 1/24/2024 Mirae Asset Global Investments Co. Ltd.3,108,473$804K0.0%+230.5%6.107% 11/13/2023Cambria Investment Management L.P.171,570$102K0.0%+184.8%0.382% 10/26/2023 Mirae Asset Global Investments Co. Ltd.940,602$557K0.0%-20.5%2.093% 10/17/2023Atlas Brown Inc.43,500$26K0.0%N/A0.097% 10/11/2023 Praetorian Wealth Management Inc.200,000$118K0.0%+700.0%0.445% Get the Latest News and Ratings for MYMD and Related StocksEnter your email address below to receive the latest news and analysts' ratings for MyMD Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. 8/10/2023 Mirae Asset Global Investments Co. Ltd.1,183,616$1.78M0.0%+0.9%2.902% 5/11/2023Cambria Investment Management L.P.61,956$107K0.0%-10.0%0.157% 5/4/2023 Mirae Asset Global Investments Co. Ltd.1,173,610$2.02M0.0%+55.1%2.973% 4/25/2023Parallel Advisors LLC25,125$43K0.0%N/A0.064% 2/9/2023 Mirae Asset Global Investments Co. Ltd.756,485$870K0.0%+18.5%1.917% 1/30/2023 International Assets Investment Management LLC67,000$77K0.0%N/A0.170% 1/20/2023 Fidelis Capital Partners LLC38,590$51K0.1%N/A0.098% 1/11/2023 Praetorian Wealth Management Inc.25,000$29K0.0%+66.7%0.063% 11/10/2022ExodusPoint Capital Management LP34,456$90K0.0%N/A0.087% 11/8/2022Cambria Investment Management L.P.65,398$171K0.0%N/A0.166% 11/7/2022Bridgecreek Investment Management LLC65,000$170K0.0%N/A0.165% 10/25/2022Raymond James Financial Services Advisors Inc.24,801$65K0.0%N/A0.065% 10/21/2022Aaron Wealth Advisors LLC50,000$131K0.0%N/A0.131% 8/12/2022Ikarian Capital LLC81,089$176K0.0%-38.3%0.213% 7/26/2022 Mirae Asset Global Investments Co. Ltd.1,073,765$2.33M0.0%+13.8%2.821% 7/18/2022Western Wealth Management LLC27,050$115K0.0%-11.9%0.071% 7/14/2022 Praetorian Wealth Management Inc.15,000$32K0.0%N/A0.039% 7/8/2022 Taylor & Morgan Wealth Management LLC17,086$37K0.0%N/A0.045% 6/2/2022 Mirae Asset Global Investments Co. Ltd.943,667$4.40M0.0%+23.5%2.479% 5/24/2022M Holdings Securities Inc.70,909$330K0.0%N/A0.186% 5/17/2022Shay Capital LLC321,187$1.50M0.2%-10.2%0.844% 5/10/2022 Mirae Asset Global Investments Co. Ltd.151,751$707K0.0%-80.1%0.399% 5/10/2022Western Wealth Management LLC30,713$143K0.0%N/A0.081% 2/15/2022Shay Capital LLC357,790$2.17M0.4%+81.4%0.951% 2/15/2022683 Capital Management LLC59,410$360K0.0%N/A0.158% 2/10/2022Qube Research & Technologies Ltd21,674$131K0.0%N/A0.058% 2/8/2022 Mirae Asset Global Investments Co. Ltd.764,245$4.63M0.0%-32.5%2.030% 2/7/2022 Corundum Group Inc.19,600$119K0.1%+74.4%0.052% 2/1/2022Qube Research & Technologies Ltd21,674$131K0.0%N/A0.058% 1/21/2022 Taylor & Morgan Wealth Management LLC17,836$108K0.1%N/A0.047% 11/15/2021Invesco Ltd.235,194$1.69M0.0%N/A0.629% 11/12/2021Geode Capital Management LLC285,671$2.06M0.0%+5.4%0.764% 11/12/2021 NorthRock Partners LLC1,354,004$9.75M0.8%-6.5%3.623% 11/9/2021BlackRock Inc.146,633$1.06M0.0%+42.3%0.392% 625,000% Gain (Ad)Imagine swapping your daily coffee expense for a future free of financial worries. It might seem far-fetched, but results like this are within reach with the right knowledge and timing in the altcoin market. Plus, you’ll get $10 in real Bitcoin when you stay to the end of the call and take a short quiz.>> Dive into the Workshop Here8/19/2021M Holdings Securities Inc.70,909$447K0.0%N/A0.192% 8/16/2021Morgan Stanley714,251$4.50M0.0%N/A1.937% 8/16/2021Charles Schwab Investment Management Inc.13,965$88K0.0%N/A0.038% 8/16/2021State Street Corp26,063$164K0.0%N/A0.071% 8/16/2021Shay Capital LLC562,200$3.54M0.4%N/A1.524% 8/13/2021Northern Trust Corp23,049$145K0.0%N/A0.062% 8/13/2021Geode Capital Management LLC271,083$1.71M0.0%N/A0.735% 8/13/2021Vanguard Group Inc.1,525,321$9.61M0.0%N/A4.136% 8/12/2021 NorthRock Partners LLC1,448,180$9.12M0.8%N/A3.927% (Data available from 1/1/2016 forward) MYMD Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of MYMD shares? During the previous two years, 9 institutional investors and hedge funds held shares of MyMD Pharmaceuticals. The most heavily invested institutionals were Mirae Asset Global Investments Co. Ltd. ($2.09M), Bridgecreek Investment Management LLC ($170K), Praetorian Wealth Management Inc. ($118K), Cambria Investment Management L.P. ($102K), ExodusPoint Capital Management LP ($90K), International Assets Investment Management LLC ($77K), and Fidelis Capital Partners LLC ($51K).Learn more on MYMD's institutional investors. What percentage of MyMD Pharmaceuticals stock is owned by institutional investors? 9.64% of MyMD Pharmaceuticals stock is owned by institutional investors. Learn more on MYMD's institutional investor holdings. Which institutional investors have been buying MyMD Pharmaceuticals stock? Of the 9 institutional investors that purchased MyMD Pharmaceuticals stock in the last 24 months, the following investors and hedge funds have bought the highest volume of shares: Mirae Asset Global Investments Co. Ltd. ($2.71M), Praetorian Wealth Management Inc. ($185K), Cambria Investment Management L.P. ($176.73K), International Assets Investment Management LLC ($67K), Bridgecreek Investment Management LLC ($65K), Atlas Brown Inc. ($43.50K), and Fidelis Capital Partners LLC ($38.59K). How much institutional buying is happening at MyMD Pharmaceuticals? Institutional investors have bought a total of 3,348,311 shares in the last 24 months. This purchase volume represents approximately $66.92M in transactions. Which MyMD Pharmaceuticals major shareholders have been selling company stock? The following institutional investors have sold MyMD Pharmaceuticals stock in the last 24 months: Mirae Asset Global Investments Co. Ltd. ($2.48M), and Cambria Investment Management L.P. ($6.88K). How much institutional selling is happening at MyMD Pharmaceuticals? Institutional investors have sold a total of 2,482,438 shares in the last 24 months. This volume of shares sold represents approximately $10.01M in transactions. Related Companies AWH Major Shareholders INAB Major Shareholders PMCB Major Shareholders AVTX Major Shareholders TRIB Major Shareholders CARA Major Shareholders BIOR Major Shareholders SNSE Major Shareholders IPA Major Shareholders AIM Major Shareholders This page (NASDAQ:MYMD) was last updated on 11/2/2024 by MarketBeat.com Staff From Our Partners625,000% GainImagine swapping your daily coffee expense for a future free of financial worries. It might seem far-fetche...Crypto Swap Profits | SponsoredEx WH Advisor Who Predicted Biden Leaving Race Makes Startling New PredictionFormer advisor to the CIA, the Pentagon and the White House Jim Rickards went on multiple TV news programs… ...Paradigm Press | SponsoredSell NVDA Now?Guess who's selling NVDA next The most successful hedge fund in history quietly sold 500,000 shares. Here's...Chaikin Analytics | SponsoredMarket "Famine" ComingMarket Wizard Larry Benedict accurately predicted that all indexes would be negative in 2022... He predicte...Opportunistic Trader | SponsoredThe centerpiece of Trump’s crypto’s masterplan …Donald Trump wants to be America’s first crypto president. He was the keynote speaker at the recent Bitcoin...Weiss Ratings | SponsoredBlackrock’s Sending THIS Crypto Higher on PurposeIt's a groundbreaking opportunity that could be poised for extraordinary gains. The catalyst behind this su...Crypto 101 Media | SponsoredThe Final FrontierAnd a lot of powerful investors would rather this exposé never saw the light of day. I suspect they’ll attempt...Porter & Company | SponsoredWall St. Legend: Millions of Americans About to Fall Out of the 1%Wall Street insider reveals the financial tidal wave about to knock millions of Americans out of the One Perce...InvestorPlace | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding MyMD Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share MyMD Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
